![Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors | Stroke Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors | Stroke](https://www.ahajournals.org/cms/asset/b3c35a70-00b3-4f6e-96f9-554efbb66e72/strokeaha.120.032704.fig03.jpg)
Stroke Prevention by Anticoagulants in Daily Practice Depending on Atrial Fibrillation Pattern and Clinical Risk Factors | Stroke
![PDF) Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial. PDF) Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial.](https://i1.rgstatic.net/publication/321397463_Impact_of_Age_and_Gender_on_Clinical_Outcomes_in_the_Edoxaban_versus_Warfarin_in_Subjects_Undergoing_Cardioversion_of_Atrial_Fibrillation_ENSURE-AF_Randomized_Trial/links/5a2dcfcf45851552ae7eef66/largepreview.png)
PDF) Impact of Age and Gender on Clinical Outcomes in the Edoxaban versus Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation (ENSURE-AF) Randomized Trial.
![2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) | Circulation 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) | Circulation](https://www.ahajournals.org/cms/asset/6c151c8f-ea89-4d42-acac-f3af1991cc9c/cir.0b013e3181fa3cf4.fp.png)
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline) | Circulation
![PDF) RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers PDF) RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers](https://i1.rgstatic.net/publication/232248646_RHYTHM-AF_design_of_an_international_registry_on_cardioversion_of_atrial_fibrillation_and_characteristics_of_participating_centers/links/004635224ffa85e2a0000000/largepreview.png)
PDF) RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers
Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF
![PDF) Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry PDF) Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry](https://i1.rgstatic.net/publication/350643060_Risk_profile_antithrombotic_treatment_and_clinical_outcomes_of_patients_in_Nordic_countries_with_atrial_fibrillation_-_results_from_the_GARFIELD-AF_registry/links/60a0f83992851cfdf3388a45/largepreview.png)
PDF) Risk profile, antithrombotic treatment and clinical outcomes of patients in Nordic countries with atrial fibrillation – results from the GARFIELD-AF registry
![Pages intimes, correspondance et journal, 1925-1926 - Jean-Yves Le Heuzey - Librairie Mollat Bordeaux Pages intimes, correspondance et journal, 1925-1926 - Jean-Yves Le Heuzey - Librairie Mollat Bordeaux](https://media.electre-ng.com/images/image-id/3b9cad0b68ddbd14c1379f2a3596e68db68a84f28c84b3b84c32b05c11c445e0.jpg)